Abstract
Objective
To evaluate the effect of flumazenil on hepatic encephalopathy complicating fulminant liver failure in children.
Design
Uncontrolled prospective study.
Setting
Pediatric Intensive Care Unit, tertiary care center.
Patients
9 children with fulminant liver failure and hepatic encephalopathy awaiting emergency liver transplantation
Interventions
Changes in hepatic encephalopathy grade and in electroencephalogram were recorded during the injection of a bolus of flumazenil (0.01 mg/kg/IV bolus) followed by a continuous infusion of flumazenil (0.01mg/kg/h).
Measurements and main results
Before flumazenil, 7 children had grade 2 and 2 had grade 3 hepatic encephalopathy. Flumazenil injection mediated an arousal effect in 1 child in whom encephalopathy improved from grade 3 to grade 2. This effect lasted 30 min. No clinical response was observed in other children. An improvement of EEG anomalies was observed lasting 3 min in one child. Despite continuous infusion of flumazenil, encephalopathy worsened in all children.
Conclusion
The effect of intravenous administration of flumazenil on hepatic encephalopathy in children with fulminant liver failure is inconsistent. Its efficacy is transient. The therapeutic value of flumazenil in children with fulminant liver failure awaiting a liver graft is minimal at this dosage.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bernuau J, Rueff B, Benhamou JP (1986) Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 6:97–106
Ferenci P (1991) Pathophysiology of hepatic encephalopathy. Hepatogastroenterology 38:371–376
Bosman DK, Van den Buijs CA, Haan JG, Maas MA, Chamuleau RA (1991) The effects of benzodiazepinereceptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat. Gastroenterology 101: 772–780
Bansky G, Meier PJ, Riederer E, Walser H, Ziegler WH, Schmid M (1989) Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans. Gastroenterology 97:744–750
Devictor D, Desplanques L, Debray D, Ozier Y, Dubousset AM, Valayer J, Houssin D et al (1992) Emergency liver transplantation for fulminant liver failure in infants and children. Hepatology 16:1156–1163
Baraldi M, Zeneroli ML (1992) Experimental hepatic encephalopathy: changes in the binding of gamma-aminobutyric acid. Science 216:427–433
Basile AS, Hughes RD, Harrison PM et al (1991) Elevated brain concentrations of 14-benzodiazepines in fulminant hepatic failure. N Engl J Med 325: 473–478
Steindl P, Püspok A, Druml W, Ferenci P (1991) Beneficial effect of pharmacological modulation of the GABAA-ben-zodiazepine receptor on hepatic encephalopathy in the rat: comparison with uremic encephalopathy Hepatology 14:963–968
Van der Rijt CC, de Knegt RJ, Schalm SW, Terpstra OT, Mechelse K (1990) Flumazenil does not improve hepatic encephalopathy associated with acute ischemic liver failure in the rabbit. Metab Brain Dis 5:131–141
Gyr K, Meier R (1991) Flumazenil in the treatment of portal systemic encephalopathy —an overview. Intensive Care Med 17:S39-S42
Jones EA, Basile AS, Mullen KD, Gammal SH (1990) Flumazenil: potential implications for hepatic encephalopathy. Pharmacol Ther 45:331–343
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Devictor, D., Tahiri, C., Lanchier, C. et al. Flumazenil in the treatment of hepatic encephalopathy in children with fulminant liver failure. Intensive Care Med 21, 253–256 (1995). https://doi.org/10.1007/BF01701483
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01701483